ACM
WVE icon

ADAR1 Capital Management’s Wave Life Sciences WVE Stock Holding History

ADAR1 Capital Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$326K Buy
+44,900
New +$585K 0.02% 232
2025
Q4 		– Sell
-119,067
Closed -$872K – 302
2025
Q3 		$872K Buy
119,067
+4,253
+4% +$34.4K 0.09% 107
2025
Q2 		$746K Buy
114,814
+91,714
+397% +$606K 0.12% 98
2025
Q1 		$187K Buy
23,100
+1,400
+6% +$15.3K 0.04% 150
2024
Q4 		$268K Buy
+21,700
New +$290K 0.06% 142
2024
Q3 		– Sell
-76,651
Closed -$382K – 352
2024
Q2 		$382K Buy
76,651
+46,651
+156% +$266K 0.08% 113
2024
Q1 		$185K Buy
+30,000
New +$150K 0.05% 122

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.6B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.08B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return